Bioinformatics
July 1, 2011 source: Genetic Engineering & Biotechnology News by Brad Webb Rapid Transition from Laboratory Discoveries to Commercialization Is Transforming Healthcare It’s been less than a decade since a full human genome was sequenced, but already there is talk that the promise of genomics-inspired personal medicine is not being realized. I couldn’t disagree more. […]
Read MoreJohn Steuart was a panelist at The Deal’s webcast audio seminar: Technology Transfer in the 21st Century, on May 12, 2011 (also participating as a panelist – Jeff Jensen, CEO, Fluxion Biosciences Inc. a Claremont Creek Ventures portfolio company) A recording of the seminar is now available to play online or download through 8/12/2011. Click […]
Read MoreApril 5, 2011 source: Gene Security Network press release Gene Security Network (GSN) welcomes the birth of the first baby to be born following the use of GSN’s novel Parental SupportTM technology for single gene preimplantation genetic diagnosis (PGD) and concurrent 24-chromosome screening. This test allows couples who are at risk to have children […]
Read MoreMarch 1, 2011 source: Enhanced Online News (EON) – Three Arch Partners, Hambrecht & Quist lead financing, join board – Initial investor Claremont Creek Ventures also participates – Tibion Corporation, the privately held Silicon Valley firm transforming stroke rehabilitation with its robotic Bionic Leg, announced today the successful closure of a $10.175 million financing round, a new […]
Read MoreA version of this article was originally published February 21, 2011 in The Health Care Blog Follow comments on the original blog post mHealth – otherwise known as mobile healthcare – sounds like just what the doctor ordered to help make healthcare delivery cheaper and more effective. And since the Internet today essentially resides in […]
Read MoreOctober 2010 source: Medical Device & Diagnostic Industry online The MX Q&A: Ted Driscoll, Claremont Creek Ventures Fledgling device companies can get a leg up with VC firms by developing a product that is ‘unique and protectable,’ says Tibion’s anchor investor. The cofounders of Tibion Bionic Technologies may want to send a thank-you note to […]
Read MoreMeet our team
Claremont Creek Ventures was founded in 2005 by Nat Goldhaber, John Steuart and Randy Hawks to pursue early stage investing in exceptional technology startups.
NAT GOLDHABER
Nat Goldhaber is a co-founder of Claremont Creek Ventures.
BRAD WEBB
Brad is focused on the role of genomics and biomarker data analytics in driving the next generation of diagnostics and drug development.
RANDY HAWKS
Randy Hawks is a co-founder of Claremont Creek Ventures.